Table 2. Anti-RT and Anti-HIV Activities of Inhibitors 11−18.
| HIV-1 |
||||
|---|---|---|---|---|
| compd | RT IC50a (μM) | EC50b (μM) | CC50c (μM) | TId |
| 11 | 6.2 | 0.0080 | >20 | >2500 |
| 12 | >100 | >10 | ||
| 13 | 0.17 | 0.024 | >20 | >830 |
| 14 | >100 | >10 | ||
| 15 | 9.4 | 1.1 | >20 | >18 |
| 16 | 1.5 | >10 | ||
| 17 | 13 | 4.3 | >20 | >4.7 |
| 18 | >100 | >10 | ||
| 3 | 0.040 | 0.013 | >20 | >1500 |
Concentration inhibiting enzyme activity by 50%.
Concentration inhibiting virus replication by 50%.
Concentration resulting in 50% cell death.
Therapeutic index, defined by CC50/EC50.